Pharmafile Logo

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

HSJ Awards open for entry with promise
to champion NHS on its 70th anniversary

HSJ is set to further champion the work of the NHS as it opens the entry window for the 2018 HSJ Awards – the world’s largest healthcare awards programme. Marking the 70th birthday of the NHS, this acknowledged annual benchmark of healthcare excellence will celebrate those who continue to innovate, make the greatest improvements in healthcare, and deliver the best value to patients in respect of outcomes and effectiveness.

HSJ Editor, Alistair McLellan, said: There will be plenty of celebration of the NHS’s innovation during its 70th birthday – but none larger or more prestigious than the HSJ Awards. The HSJ Awards has grown to become the biggest celebration of healthcare excellence in the world and it has been adopted by the NHS as the most effective way to recognise, celebrate and spread its greatest successes.” There are 24 categories to enter this year with six new awards reflecting the full spectrum of the NHS’s services and challenges.

Each year, HSJ Awards winners have said that the recognition has given a huge boost to their teams and organisations. They say it has enhanced their projects, raised morale and helped with securing backing and finance. The awards highlight examples of outstanding practice and innovation that help to safeguard and improve patient care. They inspire other organisations up and down the country like no other event.

Tom Cahill, winner of last year’s Chief Executive of the Year category said, “Afterwards a lot of people have been in contact. I’m just preparing to speak to a group of doctors about leadership and being a chief executive. Also, the response in my organisation has been tremendous. It does put you on the map.”

This year, a new judging stage will be introduced adding a new level of rigour, checks and balances. This will also allow HSJ to provide feedback on every entry submitted. Reinforcing the stature of the awards programme, it is anticipated that over 1,500 projects will be submitted for assessment and judging.

de Poel health+care return as headline sponsor of the HSJ Awards. Andrew Preston, Chief Executive of agency rate cap solution experts, de Poel health+care said: “This is our third year of partnership with the HSJ Awards. Each year, de Poel has witnessed first-hand how the very smallest everyday innovations to the very largest change initiatives create significant improvements to patient care delivery and improved outcomes. Behind every category, we have a chance to celebrate the extraordinary individuals and teams who power the NHS every day. We are extremely proud to be a part of this incredible recognition programme. The HSJ Awards are now open for entries from across British Healthcare with a closing deadline for all submissions on 31 May.

The full list of individual categories and entry criteria can be found on https://goo.gl/cmDP5R. For help with entering, please contact Ryan Saunders on +44 (0) 207 608 9043 or email ryan.saunders@wilmingtonhealthcare.com.

ENDS
 

For more information:
Andrew Baud, Tala, 020 3397 3383 or 07775 715775, andrew.baud@teamtala.com  

Note to Editors:
About HSJ HSJ is the only title to cover all aspects of publicly funded healthcare, providing news, analysis, best practice information and advice from the most powerful people in health, for the most powerful people in health. The HSJ audience is formed of healthcare leaders from both clinical and non-clinical backgrounds and both public and private sectors. To find out more about HSJ click here.

About Wilmington plc

Wilmington plc is a dynamic and expanding company with a common aim – turning knowledge into advantage.
Wilmington plc provides information and training to professional business markets within the Risk and Compliance, Finance, Legal and Insight sectors. Wilmington plc enables professionals and their organisations to enhance performance by providing high quality, relevant and reliable information, education and knowledge. Wilmington plc are underpinned by the core values of enhancing, enabling, collaborating and innovating. To find out more about Wilmington plc click here

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...